Advances in immunopharmacology : proceedings of the First International Conference on Immunopharmacology, July 1980, Brighton, England /

Advances in Immunopharmacology documents the proceedings of the First International Conference on Immunopharmacology held in Brighton, England, in July 1980. The volume contains 60 papers organized into 10 parts. The papers in Part I examine the pharmacology of immunotherapeutic drugs and immunotoxi...

Full description

Saved in:
Bibliographic Details
Corporate Authors: International Conference on Immunopharmacology Brighton, Sussex); Elsevier Science & Technology.
Group Author: Hadden, John W., 1939-
Published: Pergamon Press,
Publisher Address: Oxford ; New York :
Publication Dates: 1981.
Literature type: eBook
Language: English
Edition: First edition.
Subjects:
Online Access: http://www.sciencedirect.com/science/book/9780080263847
Summary: Advances in Immunopharmacology documents the proceedings of the First International Conference on Immunopharmacology held in Brighton, England, in July 1980. The volume contains 60 papers organized into 10 parts. The papers in Part I examine the pharmacology of immunotherapeutic drugs and immunotoxicology. Part II presents studies on thymic hormones. Part III is devoted to immunopharmacologic approaches to diseases other than cancer. Part IV deals with mechanisms of chemotaxis degranulation and microbicidal action. Part V focuses on cancer immunopharmacology and immunotherapy while Part VI cov.
Carrier Form: 1 online resource (ix, 517 pages) : illustrations
Bibliography: REFERENCESChapter 6. Assessment of Immunotoxicity Induced by the Environmental Chemicals 2,3,7,8-Tetrachlorodibenzo-p-dioxin, Diethylstilbestrol and Benzo (a) pyrene; ABSTRACT; INTRODUCTION; MATERIALS AND METHODS; RESULTS; DISCUSSION; REFERENCES; Chapter 7. On the Heterogeneity of Immunotherapeutic Agents; ABSTRACT; KEYWORDS; INTRODUCTION; THE EFFECT OF CYTOTOXIC IMMUNODEPRESSANTS ON IMMUNOCYTE SUBPOPULATIONS; SOME OPEN PROBLEMS IN THE CHARACTERIZATION OF IMMUNOSTIMULANTS; ACKNOWLEDGMENT; REFERENCES; Part 2: Thymic Hormones.
ISBN: 9781483145396
1483145395
Index Number: QR186
CLC: R371
Contents: Front Cover; Advances in Immunopharmacology; Copyright Page; Table of Contents; Part 1: Pharmacology of Immunotherapeuti Drugs and Immunotoxicology; Chapter 1. Immuno-enhancement and Drug Elimination Kinetics In Vivo; ABSTRACT; KEYWORDS; INTRODUCTION; HUMAN STUDIES; MOUSE STUDIES; REFERENCES; Chapter 2. Immunostimulants and Hepatic Drug Metabolism; ABSTRACT; KEYWORDS; INTRODUCTION; INFLUENCE OF C. PARVUM ON DRUG METABOLISM; RELATION OF ANTITUMOR ACTIVITY TO DEPRESSION OF DRUG METABOLISM; MECHANISM OF ACTION OF C. PARVUM; HUMORAL FACTORS; ACKNOWLEDGEMENT; REFERENCES.
Chapter 8. A Multifaceted Role forThymosin and its Composite Peptides in T-Cell RegulationABSTRACT; KEYWORDS; INTRODUCTION; THYMOSIN AND ITS COMPONENT PEPTIDES; BIOLOGY OF THE THYMOSINS; CLINICAL TRIALS WITH THYMOSIN; SUMMARY AND PERSPECTIVES; ACKNOWLEDGEMENT; REFERENCES; Chapter 9. The Effect of the Serum Thymic Factor (FTS) on Suppressor T Cells; SUPPRESSION OF CELL-MEDIATED CYTOTOXICITY; INHIBITION OF SKIN GRAFT REJECTION (Bach, 1977; SUPPRESSION OF MOLONEY VIRUS INDUCED SARCOMA IMMUNE RESPONSES; SUPPRESSION OF ANTIBODY FORMATION IN NZB MICE; PREVENTION OF AUTOIMMUNITY IN NZB AND B/W MICE.
IN VITRO RESTORATION OF SUPPRESSOR FUNCTION IN HUMAN LUPUSDISCUSSION AND CONCLUSIONS; REFERENCES; Chapter 10. The Influence of Thymic Humoral Factor on Immunoproliferative Disorders andViral Infections in Humans; ABSTRACT; KEYWORDS; INTRODUCTION; MATERIALS AND METHODS; RESULTS AND DISCUSSION; CONCLUSIONS; REFERENCES; Part 3: Immunopharmacologic Approaches to Diseasesother than Cancer; Chapter 11. Virus Induced Immunomodulation; INTERACTION OF MICROBES WITH THE IMMUNE SYSTEM; FRIEND LEUKEMIA VIRUS INDUCED IMMUNOSUPPRESSION; DISCUSSION AND CONCLUSIONS; SUMMARY; REFERENCES.